This update covers a range of recent health news from Dr. Oz's Medicaid stance, the US FDA's vaccine recommendations, and the resignation of FDA's counsel, to global challenges like China's drug ...
Akeso's immunotherapy drug allowed half of its patients to go 11.1 months without their condition worsening Chinese drug ...
Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback